Practical Insights on How to Improve Comprehensive Biomarker Testing in Advanced Non-Small Cell Lung Cancer

Explore opportunities to expand multidisciplinary care collaboration and coordination to improve care for patients with non-melanoma skin cancers.

T​his webinar will highlight how community cancer programs are using a new approach to optimize biomarker testing processes through the addition of a precision medicine steward.

Sign-up for the third webinar in a 6-part series, titled, “Addressing the High Cost of Radiology Services.”

Sign-up for the second in a 6-part series, titled, “Proactive Interventions for the Prior Authorization Process”

Sign-up for the first in a 6-part series, titled, “Proactive Interventions for the Prior Authorization Process”

Raise awareness among cancer programs of new treatment options for newly diagnosed patients with multiple myeloma ineligible for transplant.

Oncology state society leaders from the Appalachian Community Cancer Alliance share an introduction to the Alliance, their insights into the unique needs of the Appalachian region and beyond, how the Alliance is responding and how you can get involved.

This educational initiative will focus on multidisciplinary education surrounding TILs, with an emphasis on the importance of implementing clinical trials in the community setting.

The COVID-19 pandemic has affected treatment patterns for patients with CLL. Javier Munoz, MD, MS, FACP, Senior Associate Consultant in the Division of Hematology and Medical Oncology at the Mayo Clinic (Arizona) will discuss considerations for treating patients with CLL in the pandemic--including options for treatment, best timing for treatment, and any changes to the usual treatment regimen. Dr. Munoz will also explore what care may look like for patients with CLL beyond COVID-19.